Zobrazeno 1 - 10
of 35
pro vyhledávání: '"T. V Sologub"'
Autor:
M. G. Romantsov, T. V. Sologub, L. G. Goryacheva, S. N. Kovalenko, D. S. Sukhanov, A. A. Shuldyakov, A. N. Bondarenko, A. L. Kovalenko, A. YU. Petrov
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 3-4, Pp 45-55 (2020)
The aspects of virus hepatitis C immunopathogenesis are discussed. The main attention is paid to higher production of Th1 cytokines providing active protection of the host from HCV. The up-to-date approaches to the therapy of chronic hepatitis C, des
Externí odkaz:
https://doaj.org/article/2483971c6eee4b92a5a03fd48bd27909
Publikováno v:
Антибиотики и Химиотерапия, Vol 56, Iss 1-2, Pp 22-28 (2020)
The efficacy of the use of triple schemes in combined therapy of chronic virus hepatitis was estimated and its safety was monitored. The problems of therapy of mixed hepatitis in drug addicts are discussed. Immunotropic agents, increasing the efficac
Externí odkaz:
https://doaj.org/article/563392cb995f46a1aa04f10e7b5c07f3
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 11-12, Pp 39-51 (2020)
The authors' findings and literature data on the pharmacotherapeut efficacy of cycloferon, an interferon inductor (immunomodulators) are described. The drug effect in the treatment of various socially significant children' diseases, including acute r
Externí odkaz:
https://doaj.org/article/796dc41f1bab49faa3fd8e01c9a4198d
Autor:
V. V. Stelmakh, M. G. Romantsov, T. V. Sologub, A. A. Shuldyakov, V. K. Kozlov, N. Kh. Tuan, M. .. Ovungerel, V. M. Frolov
Publikováno v:
Антибиотики и Химиотерапия, Vol 58, Iss 9-10, Pp 27-33 (2020)
Comparative placebo-controlled study entrolled 647 patients with verified diagnosis of chronic virus hepatitis B (HBeAg+), not previously subjected to antiviral therapy (with nucleotide analogues or interferons). The drug under the investigation was
Externí odkaz:
https://doaj.org/article/1364c2c804784df09d8fe5faf1bb38bd
Autor:
T. V. Sologub, A. A. Shuldyakov, L. G. Goryacheva, I. P. Baranova, YU. N. Linkova, A. L. Kovalenko, M. G. Romantsov
Publikováno v:
Антибиотики и Химиотерапия, Vol 55, Iss 9-10, Pp 37-41 (2020)
The best therapeutic effect in the treatment of patients with chronic hepatitis B was observed with the use of cycloferon in the scheme of the antiviral therapy. The combination of cycloferon with lamivudine provided complete stable remission in 54.1
Externí odkaz:
https://doaj.org/article/90c1df6ab07f4d819df9e5881b40f999
Autor:
T. V. Sologub, A. A. Shuldyakov, M. G. Romantsov, A. N. Zhekalov, S. V. Petlenko, M. K. Erofeeva, V. L. Maksakova, V. A. Isakov, V. V. Zarubaev, V. V. Gatsan, A. L. Kovalenko
Publikováno v:
Антибиотики и Химиотерапия, Vol 54, Iss 7-8, Pp 30-36 (2020)
Data on the study of the efficacy of the tablets of cycloferon, an early inductor of types 1 and 2 interferon, in the treatment of influenza and acute respiratory tract viral infections in adults are presented. The study enrolled 522 patients with mo
Externí odkaz:
https://doaj.org/article/23dfcaa303c545fda8739ee6a7f12384
Autor:
T V Sologub, V V Tsvetkov
Publikováno v:
Терапевтический архив, Vol 89, Iss 8, Pp 113-119 (2017)
The article provides the summarized data of clinical trials evaluating the efficacy and safety of kagocel used to prevent and treat influenza and acute respiratory viral infections of different etiologies. The results of numerous preclinical and clin
Externí odkaz:
https://doaj.org/article/1087c14674154f62bb735f6ba0886891
Publikováno v:
Медицинский совет, Vol 0, Iss 7, Pp 54-58 (2015)
Acute respiratory diseases (ARD) are the most common in the structure of all infectious diseases. High antigenic variation of influenza viruses, adenoviruses and rhinoviruses slows down the process of creation of universal vaccines and leads to high
Externí odkaz:
https://doaj.org/article/3c834f32a5bd4d719e158dfbc5870c3d
Autor:
T. V. Sologub
Publikováno v:
Медицинский совет, Vol 0, Iss 4, Pp 36-45 (2015)
Influenza is an acute infectious disease caused by influenza virus (Orthomyxoviridae family) which affects up to 15% of the world population in the cold season. The relevance of the disease is reflected in the statistics: every year, up to 500 millio
Externí odkaz:
https://doaj.org/article/afd9a0fee854495eac9f5fe5933aa073
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 102-107 (2015)
According to the World Health Organization (WHO), 3 to 5 million cases of influenza are registered every year worldwide, of which 250--500 thousand are fatal. Epidemics of influenza and acute respiratory viral infections occur most often in winter, h
Externí odkaz:
https://doaj.org/article/7fa8486dcaa744b5a144102ab501aa61